FI119995B - Menetelmä reseptorikimeerojen avulla immuniteettia uudelleensuuntavien solujen valmistamiseksi - Google Patents

Menetelmä reseptorikimeerojen avulla immuniteettia uudelleensuuntavien solujen valmistamiseksi Download PDF

Info

Publication number
FI119995B
FI119995B FI960178A FI960178A FI119995B FI 119995 B FI119995 B FI 119995B FI 960178 A FI960178 A FI 960178A FI 960178 A FI960178 A FI 960178A FI 119995 B FI119995 B FI 119995B
Authority
FI
Finland
Prior art keywords
cells
cell
receptor
kinase
leu
Prior art date
Application number
FI960178A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI960178A (fi
FI960178A0 (fi
Inventor
Brian Seed
Charles Romeo
Waldemar Kolanus
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of FI960178A publication Critical patent/FI960178A/fi
Publication of FI960178A0 publication Critical patent/FI960178A0/fi
Application granted granted Critical
Publication of FI119995B publication Critical patent/FI119995B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • AIDS & HIV (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI960178A 1993-07-16 1996-01-15 Menetelmä reseptorikimeerojen avulla immuniteettia uudelleensuuntavien solujen valmistamiseksi FI119995B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9321093A 1993-07-16 1993-07-16
US9321093 1993-07-16
PCT/US1994/006675 WO1995002686A1 (en) 1993-07-16 1994-06-14 Redirection of cellular immunity by receptor chimeras
US9406675 1994-06-14

Publications (3)

Publication Number Publication Date
FI960178A FI960178A (fi) 1996-01-15
FI960178A0 FI960178A0 (fi) 1996-01-15
FI119995B true FI119995B (fi) 2009-05-29

Family

ID=22237762

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960178A FI119995B (fi) 1993-07-16 1996-01-15 Menetelmä reseptorikimeerojen avulla immuniteettia uudelleensuuntavien solujen valmistamiseksi

Country Status (18)

Country Link
EP (1) EP0804552B1 (hu)
JP (2) JP3588115B2 (hu)
KR (1) KR100278352B1 (hu)
AT (1) ATE236973T1 (hu)
AU (2) AU686646B2 (hu)
CA (1) CA2166102C (hu)
CZ (1) CZ291754B6 (hu)
DE (1) DE69432487T2 (hu)
DK (1) DK0804552T3 (hu)
ES (1) ES2197166T3 (hu)
FI (1) FI119995B (hu)
HU (1) HU224137B1 (hu)
NO (1) NO316942B1 (hu)
NZ (1) NZ269312A (hu)
PT (1) PT804552E (hu)
RU (1) RU2158305C2 (hu)
WO (1) WO1995002686A1 (hu)
ZA (1) ZA945204B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319494B1 (en) 1990-12-14 2001-11-20 Cell Genesys, Inc. Chimeric chains for receptor-associated signal transduction pathways
US6407221B1 (en) 1990-12-14 2002-06-18 Cell Genesys, Inc. Chimeric chains for receptor-associated signal transduction pathways
US6004811A (en) 1991-03-07 1999-12-21 The Massachussetts General Hospital Redirection of cellular immunity by protein tyrosine kinase chimeras
US7049136B2 (en) 1991-03-07 2006-05-23 The General Hospital Corporation Redirection of cellular immunity by receptor chimeras
US5851828A (en) 1991-03-07 1998-12-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US5912170A (en) * 1991-03-07 1999-06-15 The General Hospital Corporation Redirection of cellular immunity by protein-tyrosine kinase chimeras
US6753162B1 (en) 1991-03-07 2004-06-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US5837544A (en) * 1995-02-02 1998-11-17 Cell Genesys, Inc. Method of inducing a cell to proliferate using a chimeric receptor comprising janus kinase
US6103521A (en) * 1995-02-06 2000-08-15 Cell Genesys, Inc. Multispecific chimeric receptors
GB9526131D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Recombinant chimeric receptors
US6420140B1 (en) 1996-10-11 2002-07-16 Abgenix, Inc. Production of multimeric protein by cell fusion method
US5916771A (en) * 1996-10-11 1999-06-29 Abgenix, Inc. Production of a multimeric protein by cell fusion method
GB9809658D0 (en) * 1998-05-06 1998-07-01 Celltech Therapeutics Ltd Biological products
US20130310387A1 (en) 2012-05-16 2013-11-21 Novartis Ag Monocyclic Heteroaryl Cycloalkyldiamine Derivatives
CA3093078A1 (en) 2018-03-06 2019-09-12 The Trustees Of The University Of Pennsylvania Prostate-specific membrane antigen cars and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851828A (en) * 1991-03-07 1998-12-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
IL101147A (en) * 1991-03-07 2004-06-20 Gen Hospital Corp Change of direction of cellular immunity by chimera receptors

Also Published As

Publication number Publication date
EP0804552A4 (en) 1999-07-14
CA2166102A1 (en) 1995-01-26
FI960178A (fi) 1996-01-15
FI960178A0 (fi) 1996-01-15
KR100278352B1 (ko) 2001-01-15
HU224137B1 (hu) 2005-05-30
HUT74252A (en) 1996-11-28
WO1995002686A1 (en) 1995-01-26
RU2158305C2 (ru) 2000-10-27
NZ269312A (en) 1998-02-26
CA2166102C (en) 2008-03-18
PT804552E (pt) 2003-08-29
AU712245C (en) 2004-10-28
NO316942B1 (no) 2004-07-05
ES2197166T3 (es) 2004-01-01
EP0804552A1 (en) 1997-11-05
AU7314094A (en) 1995-02-13
CZ291754B6 (cs) 2003-05-14
ZA945204B (en) 1995-05-30
JP2004222735A (ja) 2004-08-12
DE69432487T2 (de) 2004-04-08
NO960175D0 (no) 1996-01-15
NO960175L (no) 1996-03-15
DK0804552T3 (da) 2003-07-28
AU6476798A (en) 1998-07-02
AU712245B2 (en) 1999-11-04
JP3738024B2 (ja) 2006-01-25
HU9600084D0 (en) 1996-03-28
CZ340895A3 (en) 1996-08-14
ATE236973T1 (de) 2003-04-15
AU686646B2 (en) 1998-02-12
JP3588115B2 (ja) 2004-11-10
EP0804552B1 (en) 2003-04-09
JPH09500020A (ja) 1997-01-07
DE69432487D1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
AU703125B2 (en) Redirection of cellular immunity by protein-tyrosine kinase chimeras
US6392013B1 (en) Redirection of cellular immunity by protein tyrosine kinase chimeras
KR100257780B1 (ko) 수용체 키메라에 의한 세포 면역성의 재유도방법에 사용되는 약제
FI119757B (fi) Solut, jotka ilmentävät kimeeristen reseptorien yhdistelmää, ja niiden käyttö terapiassa
FI119995B (fi) Menetelmä reseptorikimeerojen avulla immuniteettia uudelleensuuntavien solujen valmistamiseksi

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119995

Country of ref document: FI

MA Patent expired